Overview


According to FutureWise analysis the market for osteoarthritis therapeutics is expected to reach US$ 18.37 billion by 2031 at a CAGR of 8.9%.

A chronic degenerative joint condition is osteoarthritis (OA), which primarily affects the cartilage in joints, causing it to break down and eventually wear away. As a result, the bones in the joint may begin to rub against one another, leading to pain, stiffness, and reduced mobility. OA might affect any joint, but it most commonly affects the knees, hips, and hands. There is currently no permanent remedy for OA, and treatment primarily focuses on managing symptoms and slowing down disease progression. Osteoarthritis therapeutics include a variety of approaches, such as medication, physical therapy, and surgery. Medication is often used to manage pain and inflammation associated with OA. Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are commonly used to manage pain, while corticosteroids and hyaluronic acid injections can be used to reduce inflammation and improve joint mobility.

Physical therapy is another important component of OA treatment. Physical therapy exercises can help improve joint mobility and flexibility, strengthen muscles, and reduce pain and stiffness. Occupational therapy can also be helpful in teaching patients how to manage daily activities with reduced joint mobility. Surgery is necessary for patients with severe OA who do not respond to other treatments. Joint replacement surgery, such as knee or hip replacement, involves removing damaged joint tissue and replacing it with an artificial joint made of plastic, metal, or ceramic.

FutureWise Market Research has published a report that provides an insightful analysis of Osteoarthritis Therapeutics Market trends affecting overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Osteoarthritis Therapeutics Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.
  • Sanofi
  • Horizon Therapeutics PLC
  • Johnson & Johnson
  • Glaxosmithkline PLC
  • Bayer AG
  • Abbott
  • Pfizer, Inc.
  • Eli Lilly
  • Anika Therapeutics, Inc.
  • Novartis
  • Ferring Pharmaceuticals
  • Bioventus
  • Zimmer Biomet Holdings, Inc.
  • Fidia Farmaceutici S.P.A.
  • Flexion Therapeutics, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Osteoarthritis Therapeutics Market:

In August 2022, A licensing agreement was made between Hionogi & Co., Ltd. and Grünenthal GmbH to market injectable resiniferatoxin, a Grünenthal pipeline product, in Japan. Patients with knee osteoarthritis can use it to relieve their discomfort.

The global osteoarthritis therapeutics market is driven by several factors, including the increasing prevalence of OA, growing elderly population, and the rising awareness of the disease and its management. One of the major drivers of the osteoarthritis therapeutics market is the increasing prevalence of OA worldwide. According to the World Health Organization (WHO), OA is one of the most widespread musculoskeletal disorders, affecting over 300 million people globally. As the aging population continues to grow, the incidence of OA is expected to increase, thereby driving the demand for effective therapeutics. Another key driver of the market is the growing geriatric population. The major risk factor for the occurrence of OA is aging, and as the global population continues to age, the demand for effective therapeutics for OA is expected to rise. Moreover, the geriatric population is also more likely to suffer from comorbidities, such as obesity and diabetes, which can exacerbate OA symptoms and increase the need for effective treatment. The rising awareness of the disease and its management is also contributing to the growth of the osteoarthritis therapeutics market. There has been a significant increase in public awareness of the disease and its impact on quality of life, leading to greater demand for effective treatment options. Furthermore, governments and healthcare organizations are also increasing their efforts to raise awareness and improve access to treatment options for patients with OA.

However, there are also several challenges that may impede the growth of the osteoarthritis therapeutics market. One of the major challenges is the high cost of treatment, which can be a barrier to access for many patients. Moreover, the lack of effective disease-modifying therapies is also a significant challenge, as current treatments mainly focus on symptom relief rather than disease modification.

By Anatomy

  • Knee
  • Hip
  • Hand
  • Small Joints (Foot & Ankle and Wrist)

By Drug Type

  • Viscosupplementation Agents
  • Nonsteroidal Anti-inflammatory Drugs
    •   Naproxen
    •   Aspirin
    •   Diclofenac
    •   Ibuprofen
    •   Other NSAIDs
  • Analgesics
    •   Duloxetine
    •   Acetaminophen
  • Corticosteroids

By Route of Administration

  • Parenteral
  • Topical
  • Oral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Purchasing Pattern

  • Prescription Drug
  • Over-the-counter Drug

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Europe registered the highest share in the market in 2022. A rise in the prevalence of chronic illnesses, a rise in the geriatric population, and changes in people's lifestyles are all contributing to market expansion in Europe. Thus, a variety of therapies and medications are becoming more popular in the region. Additionally, the availability of improved treatment alternatives, government reimbursement guidelines, growing R&D efforts to create innovative medicines, and the introduction of new treatments in the European region are all anticipated to support market expansion. Additionally, based on Distribution Channel; Hospital Pharmacies segment holds the biggest market share in 2022.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Osteoarthritis Therapeutics Market By Anatomy, By Drug Type, By Route of Administration, By Distribution Channel, By Purchasing Pattern and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Osteoarthritis Therapeutics Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Osteoarthritis Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Osteoarthritis Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Osteoarthritis Therapeutics Market, By Anatomy Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Knee
        2. Hip
        3. Hand
        4. Small Joints (Foot and Ankle and Wrist)

  • 8.   Osteoarthritis Therapeutics Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Viscosupplementation Agents
        2. Nonsteroidal Anti-inflammatory Drugs
         2.1. Naproxen
         2.2. Aspirin
         2.3. Diclofenac
         2.4. Ibuprofen
         2.5. Other NSAIDs
        3. Analgesics
         3.1. Duloxetine
         3.2. Acetaminophen
        4. Corticosteroids

  • 9.   Osteoarthritis Therapeutics Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Parenteral
        2. Topical
        3. Oral

  • 10.   Osteoarthritis Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 11.   Osteoarthritis Therapeutics Market, By Purchasing Pattern Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Prescription Drug
        2. Over-the-counter Drug

  • 12.   North America Osteoarthritis Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Osteoarthritis Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Osteoarthritis Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Osteoarthritis Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Sanofi
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Horizon Therapeutics PLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Johnson and Johnson
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Glaxosmithkline PLC
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bayer AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abbott
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pfizer, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lilly
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Anika Therapeutics, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Novartis
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Ferring Pharmaceuticals
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Bioventus
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Zimmer Biomet Holdings, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
          14. Fidia Farmaceutici S.P.A.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Flexion Therapeutics, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11